Trial Radar
Sign in

NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI
Early Identification of Brain Lesions in Multiple Sclerosis With Phase Sensitive Inversion Recovery MRI

NCT06955832

RecruitingN/A

Sponsor: Benha University

Conditions: Multiple Sclerosis

Countries: Egypt

The goal of this observational study is to compare the diagnostic accuracy of Phase-Sensitive Inversion Recovery (PSIR) MRI versus conventional T2-weighted (T2W) and Fluid Attenuated Inversion Recovery (FLAIR) sequences in detecting early brain lesions in patients with Multiple Sclerosis (MS). The study will include male and female participants aged 15-65 years diagnosed with MS per the 2017 McDonald criteria. This study hypothesizes that: * PSIR MRI will detect a significantly higher number of cortical lesions (intracortical, leukocortical, and juxtacortical) compared to conventional T2W and FLAIR sequences in MS patients (p \< 0.05). * Lesions identified exclusively by PSIR will correlate more strongly with clinical measures (EDSS disability scores and SDMT cognitive performance) than those detected by T2W/FLAIR alone, suggesting PSIR's superior sensitivity to clinically relevant pathology.

Eligibility overview

Sex: ALL

Age: 15 Years to 65 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Age between 15-65 years.
* Both sexes.
* Patients with MS according to McDonald Criterion

Exclusion Criteria:

* Age less than 15 years old.
* Patients with stroke or previous intracranial hemorrhage.
* Contraindications to MRI scans.
* MS mimics.
Locations (3)
  • Banhā, Qalyubia Governorate, Egypt
  • Cairo, Egypt
  • Cairo, Egypt